ASA
What it isIrreversible COX-1 and COX-2 inhibitor; secondary cardiovascular prevention, acute coronary syndrome and stroke.
Why this oneIts irreversible platelet effect persists for each platelet's lifespan, distinguishing it from other NSAIDs.
What limits itGI bleeding limits use; primary prevention rarely justifies it. Avoid in viral illness in children; ibuprofen taken first blunts platelet effect.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Not stated in fetched sections (OTC analgesic/antipyretic label — Uses/Purpose section absent) | Adults & children ≥12 yr | 4 tablets q4h PRN | 4–8 tablets q4h PRN while symptoms last | 48 tablets/24 h |
Renal Undefined
Hepatic Undefined
Dose expressed in tablets only — tablet strength (mg) is not stated in any fetched section.
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskGI bleeding, and Reye syndrome in children

Open Aspirin in the interactive console ↗

